Table 2.
FLIP classification | n | Midazolam, mg; median (IQR) |
Fentanyl, mcg; median (IQR) |
Propofol, n (%) |
---|---|---|---|---|
Abnormal EGJ-DI | 117 | 7 (5 – 9) | 150 (125 – 200) | 8 (7) |
Normal EGJ-DI | 28 | 8 (5 – 9) | 150 (125 – 200) | 2 (7) |
Abnormal FLIP
topography |
123 | 7 (5 – 9) | 150 (125 – 200) | 8 (7) |
Normal FLIP
topography |
22 | 8 (5 – 9) | 150 (119 – 200) | 2 (9) |
Achalasia without
contractility |
29 | 7 (6 – 10) | 163 (125 – 200) | 3 (10) |
Spastic achalasia | 44 | 5 (5 – 9) | 125 (125 – 200) | 4 (9) |
EGJOO | 44 | 7 (5 – 8) | 150 (125 – 175) | 1 (2) |
Spastic motor
disorder |
5 | 9 (7 – 10) | 200 (175 – 200) | 0 |
Absent
contractility |
1 | 5 | 125 | 0 |
Diminished
contractility |
1 | 10 | 200 | 0 |
Normal motility | 21 | 8 (5 – 9) | 150 (113 – 188) | 2 (10) |